- Home
- VRCA vs REFR Comparison
VRCA vs REFR Comparison
Compare VRCA & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- REFR
- Stock Information
- Founded
- VRCA 2013
- REFR 1965
- Country
- VRCA United States
- REFR United States
- Employees
- VRCA N/A
- REFR N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- REFR Multi-Sector Companies
- Sector
- VRCA Health Care
- REFR Miscellaneous
- Exchange
- VRCA Nasdaq
- REFR Nasdaq
- Market Cap
- VRCA 58.0M
- REFR 56.6M
- IPO Year
- VRCA 2018
- REFR N/A
- Fundamental
- Price
- VRCA $0.72
- REFR $1.55
- Analyst Decision
- VRCA Hold
- REFR
- Analyst Count
- VRCA 5
- REFR 0
- Target Price
- VRCA $6.00
- REFR N/A
- AVG Volume (30 Days)
- VRCA 416.0K
- REFR 32.3K
- Earning Date
- VRCA 02-27-2025
- REFR 03-06-2025
- Dividend Yield
- VRCA N/A
- REFR N/A
- EPS Growth
- VRCA N/A
- REFR N/A
- EPS
- VRCA N/A
- REFR N/A
- Revenue
- VRCA $9,210,000.00
- REFR $1,469,616.00
- Revenue This Year
- VRCA $64.32
- REFR N/A
- Revenue Next Year
- VRCA $73.76
- REFR N/A
- P/E Ratio
- VRCA N/A
- REFR N/A
- Revenue Growth
- VRCA 187.45
- REFR 102.07
- 52 Week Low
- VRCA $0.61
- REFR $0.93
- 52 Week High
- VRCA $11.41
- REFR $2.41
- Technical
- Relative Strength Index (RSI)
- VRCA 46.69
- REFR 34.98
- Support Level
- VRCA $0.68
- REFR $1.53
- Resistance Level
- VRCA $0.75
- REFR $1.64
- Average True Range (ATR)
- VRCA 0.06
- REFR 0.09
- MACD
- VRCA 0.02
- REFR -0.00
- Stochastic Oscillator
- VRCA 75.35
- REFR 6.06
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.